Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout
Objective. To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
[PDF][PDF] Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout
RO DAY - The Journal of Rheumatology, 2011 - academia.edu
Objective. To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
[引用][C] Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout
SL STOCKER, GG GRAHAM… - Journal of …, 2011 - pascal-francis.inist.fr
Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in
Patients with Gout CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Patients with Gout CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout
RO DAY - The Journal of Rheumatology, 2011 - jrheum.org
Objective. To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
SL Stocker, GG Graham, AJ McLachlan… - The Journal of …, 2011 - europepmc.org
Objective To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout
SL Stocker, GG Graham… - The Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …